CTSC: A Protein Involved in Aromatic Amino Acid and Cellular Processes

Target Name: CTSC

NCBI ID: G1075

CTSC

CTSC: A Protein Involved in Aromatic Amino Acid and Cellular Processes

CTSC (Dipeptide Arylamidase I) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and liver. It is a member of the arylamidase family, which includes enzymes that are involved in the breakdown of aromatic amino acids, which are important building blocks of many molecules in the body.

One of the unique features of CTSC is its ability to break down not only aromatic amino acids, but also dipeptides, which are composed of two amino acids. This ability makes CTSC a useful tool for the study of protein structure and function, as it allows researchers to investigate the mechanisms by which proteins interact with one another.

In addition to its role in protein structure and function, CTSC has also been shown to play a key role in the regulation of many cellular processes. For example, studies have shown that CTSC is involved in the regulation of cell growth, differentiation, and metabolism, as well as the development and progression of a variety of diseases.

As a drug target, CTSC has the potential to be a treatment for a wide range of diseases. For example, CTSC has been shown to be involved in the development of certain types of cancer, and may be a useful target for these cancers. Additionally, CTSC has been shown to play a key role in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, and may be a useful target for these conditions.

Another potential use for CTSC as a drug target is its ability to modulate the immune system. Studies have shown that CTSC can be activated by certain types of cancer treatments, and may be a useful target for cancer immunotherapy. Additionally, CTSC has been shown to play a key role in the regulation of inflammation, and may be a useful target for the treatment of inflammatory diseases.

In conclusion, CTSC (Dipeptide Arylamidase I) is a protein that is expressed in various tissues throughout the body that is involved in the breakdown of aromatic amino acids and has been shown to play a key role in the regulation of many cellular processes. As a drug target, CTSC has the potential to be a treatment for a wide range of diseases, including cancer, neurodegenerative diseases, and inflammatory diseases. Further research is needed to fully understand the role of CTSC in these processes and its potential as a drug target.

Protein Name: Cathepsin C

Functions: Thiol protease (PubMed:1586157). Has dipeptidylpeptidase activity (PubMed:1586157). Active against a broad range of dipeptide substrates composed of both polar and hydrophobic amino acids (PubMed:1586157). Proline cannot occupy the P1 position and arginine cannot occupy the P2 position of the substrate (PubMed:1586157). Can act as both an exopeptidase and endopeptidase (PubMed:1586157). Activates serine proteases such as elastase, cathepsin G and granzymes A and B (PubMed:8428921)

The "CTSC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CTSC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets